Benitec Biopharma Inc. Banner Image

Benitec Biopharma Inc.

  • Ticker BNTC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Benitec Biopharma Inc. Logo Image
  • 11-50 Employees
  • Based in Melbourne, Australia
Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates forMore the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B.
4.8 / 5.0 (150)

Benitec Biopharma Inc. reports have an aggregate usefulness score of 4.8 based on 150 reviews.

Benitec Biopharma Inc.

Most Recent Annual Report

Benitec Biopharma Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Benitec Biopharma Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!